Moreover, SNPs in the NR1H2 and SLC6A20 genes, which have been previously linked to COVID-19 hospitalization and AD, were related to neurological sequelae accompanying even a mild-to-moderate disease course, and those that appeared within six months and were maintained over a long-term period after recovery, in young adults. This evidence concerns the gene SLC6A20 and COVID-19.